The clinic cites the trial's finding of fewer breathing interruptions at night in adults with obesity and sleep apnea, framing it as a benefit beyond weight loss.
Recap by typeshit. Post by @metaboliteclinic on Instagram.
Researchers found the peptide they built as a treatment already circulates in human blood, at lower levels in people with cognitive impairment.
Topol points to work suggesting the body's own GLP-1 family peptides help reduce inflammation in the gut. Details are thin, so tap through for the study.
Medscape explores whether GLP-1 medicines might help keep people with schizophrenia out of the hospital. Tap through for the evidence behind the idea.
The weight loss drug class started with a lizard. A short local feature looks at how the Gila monster led researchers to GLP-1 medicines.
A general primer describing peptides as amino acid chains that act as messengers tied to tissue repair, metabolism, hormones and immunity.
The hospital points to returning hunger, cravings and plateaus as cues, says any dose change should go through a doctor, and pushes readers to book a consult.
Loading…